what is known about trial:nct:NCT07336953

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2) NCT07336953↗ Outcome: Ongoing

Computed from the knowledge API (getStudy); every record links to its source.